Search results
Found 6703 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Oxford joins forces with 11 universities to launch social impact investment fund
General Innovation
23 June 2021
The University of Oxford has joined forces with 11 leading universities to create Impact 12, an impact investment fund to support mission-led university ventures.
Ivermectin to be investigated as a possible treatment for COVID-19 in the PRINCIPLE trial
Clinical Trials Coronavirus COVID-19 General Research
23 June 2021
From today, ivermectin is being investigated in the UK as part of the Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE), the world’s largest clinical trial of possible COVID-19 treatments for recovery at home and in other non-hospital settings.
Potential for radiotherapy and VTP multimodality therapy for prostate cancer
General Research
21 June 2021
A recent collaborative study from the University of Oxford has investigated the potential benefit of a combined therapy approach to prostate cancer treatment, using radiotherapy and vascular targeted photodynamic therapy (VTP), which could lead to first-in-man early phase clinical trials.
Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study
Coronavirus COVID-19 General Research
21 June 2021
A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.
First trimester placental scan - Artificial Intelligence in Health and Care Award
General Research
17 June 2021
A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.
Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers
Coronavirus COVID-19 General Research
17 June 2021
Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.
Oxford University and partners win government funding to evaluate Paige Prostate Cancer Detection System
General Research
16 June 2021
A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University as part of a successful NHSx Artificial Intelligence Health and Care Award application.
Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%
Coronavirus COVID-19 General Research
16 June 2021
A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.
RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients
Coronavirus COVID-19 General Research
16 June 2021
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.
Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease
General Research
15 June 2021
A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.
Professor Susan Jebb appointed as Chair of the Food Standards Agency
Awards and Appointments General
14 June 2021
Susan Jebb, Professor of Diet and Population Health in Oxford University’s Nuffield Department of Primary Care Health Sciences, has been appointed as the new Chair of the Food Standards Agency.
COVID-19 vaccine safety monitoring should account for age, gender, and database differences
Coronavirus COVID-19 General Research
14 June 2021
The largest, most extensive global network study on background rates for adverse events of special interest identifies important age, sex and database differences that should inform future safety surveillance efforts.
Oxford University academics recognised in Queen’s Birthday Honours
Awards and Appointments General
12 June 2021
The pioneering work of members of the University, including research into tackling the Coronavirus pandemic, has been recognised in The Queen's Birthday Honours List.
Two Oxford Professors elected as EMBO Members
Awards and Appointments General
10 June 2021
Professor Robert Klose and Professor Ervin Fodor are two of 64 life scientists to be elected to The European Molecular Biology Organization (EMBO).
Scientists make DNA breakthrough which could identify why some people are more affected by Covid-19
Coronavirus COVID-19 General Research
10 June 2021
Scientists from the MRC Weatherall Institute of Molecular Medicine at Oxford University have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.
PhD Student of the Year Winner!
Awards and Appointments General Staff and student stories
9 June 2021
In a record breaking year for the Postgrad Awards 2021, DPhil student Tolu Awoyemi wins PhD Student of the Year.
AI endoscopy enables 3D surface measurements of pre-cancerous condition in oesophagus
General Research
9 June 2021
Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett’s oesophagus and so determine patients most at risk of developing cancer.
The COVID-19 International Modelling Consortium (CoMo Consortium) enters a new phase
Coronavirus COVID-19 General Research
9 June 2021
Created in March 2020 to assist policymakers to make use of existing evidence in mathematical and epidemiological models to inform strategies for minimising the impact of COVID-19, the CoMo Consortium brings together mathematical modellers, epidemiologists, health economists and public health experts from more than 40 countries across Africa, Asia and South and North America.
New Head of the Department of Psychiatry – Professor Belinda Lennox
Awards and Appointments General
8 June 2021
Professor Belinda Lennox has been welcomed to the role of Head of the Department of Psychiatry at the University of Oxford and will take over leadership in October 2021.
RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19
Coronavirus COVID-19 General Research
8 June 2021
The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for patients hospitalised with COVID-19.